Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Withdrawn
Summary
- Conditions
- Renal Failure
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01507532
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Marc H Scheetz, PharmD Midwestern University
Get Well Soon